Patient dissatisfaction most common cause for multifocal lens explantations
September 14th 2008Preop chair time is vital for multifocal patients to correctly evaluate motivation and manage expectations correctly, Dr Jorge Alio told delegates during a presentation on how to rescue an unhappy multifocal patient.
Surgeon controversially shuns multifocal IOLs
September 14th 2008Monovision offers a safe and an effective option while multifocals are a high risk strategy, Dr Graham D. Barrett controversially told delegates during a session that discussed whether surgeons should introduce multifocal IOLs (MFIOLs) into their practice.
How to achieve the perfect multifocal IOL implantation
September 14th 2008Good multifocal IOL (MFIOL) candidates are highly motivated to be spectacle independent and tend to have an easy going and adaptable personality. They have healthy eyes and a low degree of astigmatism. Hyperopic presbyopes tend to make the best candidates.
Live Audio Coverage from the ESCRS Congress in Berlin
September 14th 2008Dr Douglas D. Koch talks about indications and options related to accommodating lenses, Dr Thomas F. Neuhann discusses why he prefers the femtosecond laser to the mechanical microkeratome when making LASIK flaps and Dr Jack T. Holladaytalks about using a laser versus implanting an inlay to treat presbyopia to provide good distance vision and allow patients to read without glasses or contact lenses.
Audio Coverage from Day One of the ESCRS Congress in Berlin
September 13th 2008Dr Chandrashekar Balachandran discusses what he and colleagues have learned about the causes of primary donor failure in Descemet membrane endothelial keratoplasty, Dr I. Howard Fine talks about three cases to illustrate the reasons he believes that all cases of small pupils should be treated as possible cases of intraoperative floppy iris syndrome, Dr Robert H. Osher, discusses the challenges of addressing dropped nuclei during surgery and the surprising results of a recent cadaver study he conducted, which he says overturned all of the tenets about dropped nuclei he previously held and Dr Fernando Trindade talks about the circumstances under which surgeons might consider amputating IOL haptics.
Biosyntrx introduces weight-management product into ophthalmic market
September 3rd 2008Lexington, SC, and Colorado Springs, CO-Biosyntrx Corp. is partnering with Wellosophy Corp. to include a professional-strength version of a proprietary hydrogel gastric bulking technology (Swell) into Biosyntrx’s new mealtime portion-control product (Avantrx).
Novartis launches new patient assistance program
September 3rd 2008East Hanover, NJ-Novartis Pharmaceuticals Corp. has launched the Patient Assistance Now Web site and telephone service to integrate company programs and other resources to help uninsured Americans pay for their Novartis medicines and find health-care information.
iScience receives clearance for use of microcatheters for POAG
September 3rd 2008Menlo Park, CA-iScience Interventional has received expanded 510(k) clearance from the FDA to allow ophthalmic surgeons to use its microcatheters to enlarge outflow passages to reduce IOP in the treatment of primary open-angle glaucoma (POAG).
Iridex lasers receive FDA clearance
September 3rd 2008Mountain View, CA-Iridex Corp. has received 510(k) clearance from the FDA for a family of laser systems (IQ 532, IQ 577, IQ 630-670, and IQ 810) and their associated delivery devices to deliver laser energy in three different modes (CW-Pulse, MicroPulse, and LongPulse).
Exploring New Benefits of Torsional Ultrasound: Effects on Creation of Free Radicals
September 2nd 2008Torsional ultrasound using the INFINITI? Vision System with the OZil? Torsional handpiece (Alcon Laboratories) is a unique modality that changes the dynamics of ultrasonic phacoemulsification. Compared with traditional longitudinal ultrasound, torsional ultrasound is a fundamentally different approach to phacoemulsification because the side-to-side ultrasonic oscillations shear lens material. Many cataract surgeons have quickly adopted this new modality based on the positive experiences reported by users, including significantly reduced repulsion, improved material followability, improved efficiency of lens removal, and an improved thermal profile; all contributing to improved clinical outcomes.
Optic atrophy secondary to sickle cell hyphema is avoidable
September 1st 2008Optic atrophy secondary to sickle cell hyphema can lead to permanent loss of visual acuity. Sickling should be suspected in all cases of hyphema, particularly in individuals of African American or Mediterranean descent. Because a slit-lamp examination will not reveal sickled cells, however, a lab test for sickling should be ordered.
SLT lowers IOP with favorable safety, says clinician
September 1st 2008Selective laser trabeculoplasty offers safe and effective treatment for patients with primary open-angle glaucoma and other, more difficult glaucomas, according to one ophthalmologist. It might be a reasonable first-line intervention in some situations.
Strategic marketing at the practice level
September 1st 2008Marketing at the practice level offers a less expensive and easier way to increase patient volume. Creating a memorable patient experience by showing the practice's superiority over others, starting at the consultation, as well as addressing concerns and fears at the beginning, will help retain patients and increase references.
Newer glaucoma procedures may threaten the longstanding reign of trabeculectomy, physician says
September 1st 2008Trabeculectomy remains the most commonly performed surgical glaucoma procedure. However, interest in identifying alternatives involving simpler postoperative follow-up and a better safety profile is fueling the development of newer surgical procedures.